[ORGANIZATION]
Medicines and Healthcare products Regulatory Agency (MHRA)
Featured in 7 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
343 clusters · 1318 sources · last updated
Latest: FDA issues warning for GLP-1 drugs over vision loss risks
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt
Also covered in
-
UK MHRA Issues Guidance Clarifying Regulation of AI Clinical Scribe Tools
[HEALTH] · 2 sources ·